Halozyme Therapeutics shares owned by Palisade Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Palisade Capital Management
from 13F filings
Historical chart of Palisade Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Palisade Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Palisade Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $2.5M | 2.6M | 0.95 |
| 2024-03-31 | $2.3M | 2.6M | 0.89 |
| 2023-12-31 | $2.4M | 2.8M | 0.86 |
| 2023-09-30 | $2.3M | 2.8M | 0.85 |
| 2023-06-30 | $3.1M | 3.8M | 0.83 |
| 2023-03-31 | $3.4M | 4.0M | 0.85 |
| 2022-12-31 | $3.3M | 3.4M | 0.97 |
| 2022-09-30 | $3.6M | 4.3M | 0.85 |
| 2022-06-30 | $883k | 1.0M | 0.88 |
More positions owned by Palisade Capital Management
View all positions for Palisade Capital Management